Literature DB >> 23736855

Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy.

Eric J Horstick1, Jeremy W Linsley, James J Dowling, Michael A Hauser, Kristin K McDonald, Allison Ashley-Koch, Louis Saint-Amant, Akhila Satish, Wilson W Cui, Weibin Zhou, Shawn M Sprague, Demetra S Stamm, Cynthia M Powell, Marcy C Speer, Clara Franzini-Armstrong, Hiromi Hirata, John Y Kuwada.   

Abstract

Excitation-contraction coupling, the process that regulates contractions by skeletal muscles, transduces changes in membrane voltage by activating release of Ca(2+) from internal stores to initiate muscle contraction. Defects in excitation-contraction coupling are associated with muscle diseases. Here we identify Stac3 as a novel component of the excitation-contraction coupling machinery. Using a zebrafish genetic screen, we generate a locomotor mutation that is mapped to stac3. We provide electrophysiological, Ca(2+) imaging, immunocytochemical and biochemical evidence that Stac3 participates in excitation-contraction coupling in muscles. Furthermore, we reveal that a mutation in human STAC3 is the genetic basis of the debilitating Native American myopathy (NAM). Analysis of NAM stac3 in zebrafish shows that the NAM mutation decreases excitation-contraction coupling. These findings enhance our understanding of both excitation-contraction coupling and the pathology of myopathies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23736855      PMCID: PMC4056023          DOI: 10.1038/ncomms2952

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  48 in total

Review 1.  Bridging the myoplasmic gap: recent developments in skeletal muscle excitation-contraction coupling.

Authors:  Roger A Bannister
Journal:  J Muscle Res Cell Motil       Date:  2007-09-26       Impact factor: 2.698

2.  Rem inhibits skeletal muscle EC coupling by reducing the number of functional L-type Ca2+ channels.

Authors:  R A Bannister; H M Colecraft; K G Beam
Journal:  Biophys J       Date:  2008-01-11       Impact factor: 4.033

3.  Non-sense mutations in the dihydropyridine receptor beta1 gene, CACNB1, paralyze zebrafish relaxed mutants.

Authors:  Weibin Zhou; Louis Saint-Amant; Hiromi Hirata; Wilson W Cui; Shawn M Sprague; John Y Kuwada
Journal:  Cell Calcium       Date:  2005-12-20       Impact factor: 6.817

Review 4.  Regulation of voltage-gated Ca2+ channels by calmodulin.

Authors:  D Brent Halling; Paula Aracena-Parks; Susan L Hamilton
Journal:  Sci STKE       Date:  2006-01-17

5.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Björn C Knollmann; Nagesh Chopra; Thinn Hlaing; Brandy Akin; Tao Yang; Kristen Ettensohn; Barbara E C Knollmann; Kenneth D Horton; Neil J Weissman; Izabela Holinstat; Wei Zhang; Dan M Roden; Larry R Jones; Clara Franzini-Armstrong; Karl Pfeifer
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

6.  The zebrafish shocked gene encodes a glycine transporter and is essential for the function of early neural circuits in the CNS.

Authors:  Wilson W Cui; Sean E Low; Hiromi Hirata; Louis Saint-Amant; Robert Geisler; Richard I Hume; John Y Kuwada
Journal:  J Neurosci       Date:  2005-07-13       Impact factor: 6.167

7.  Zebrafish bandoneon mutants display behavioral defects due to a mutation in the glycine receptor beta-subunit.

Authors:  Hiromi Hirata; Louis Saint-Amant; Gerald B Downes; Wilson W Cui; Weibin Zhou; Michael Granato; John Y Kuwada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

8.  De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy.

Authors:  Shirley Rainier; Carron Sher; Orit Reish; Donald Thomas; John K Fink
Journal:  Arch Neurol       Date:  2006-03

9.  Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease.

Authors:  Hiromi Hirata; Takaki Watanabe; Jun Hatakeyama; Shawn M Sprague; Louis Saint-Amant; Ayako Nagashima; Wilson W Cui; Weibin Zhou; John Y Kuwada
Journal:  Development       Date:  2007-06-27       Impact factor: 6.868

10.  The beta 1a subunit is essential for the assembly of dihydropyridine-receptor arrays in skeletal muscle.

Authors:  Johann Schredelseker; Valentina Di Biase; Gerald J Obermair; E Tatiana Felder; Bernhard E Flucher; Clara Franzini-Armstrong; Manfred Grabner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

View more
  90 in total

1.  Identification of STAC3 variants in non-Native American families with overlapping features of Carey-Fineman-Ziter syndrome and Moebius syndrome.

Authors:  Aida Telegrafi; Bryn D Webb; Sarah M Robbins; Carlos E Speck-Martins; David FitzPatrick; Leah Fleming; Richard Redett; Andreas Dufke; Gunnar Houge; Jeske J T van Harssel; Alain Verloes; Angela Robles; Irini Manoli; Elizabeth C Engle; Ethylin W Jabs; David Valle; John Carey; Julie E Hoover-Fong; Nara L M Sobreira
Journal:  Am J Med Genet A       Date:  2017-08-04       Impact factor: 2.802

Review 2.  Organization of junctional sarcoplasmic reticulum proteins in skeletal muscle fibers.

Authors:  Virginia Barone; Davide Randazzo; Valeria Del Re; Vincenzo Sorrentino; Daniela Rossi
Journal:  J Muscle Res Cell Motil       Date:  2015-09-15       Impact factor: 2.698

3.  Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies.

Authors:  Christoph Bachmann; Faiza Noreen; Nicol C Voermans; Primo L Schär; John Vissing; Johanna M Fock; Saskia Bulk; Benno Kusters; Steven A Moore; Alan H Beggs; Katherine D Mathews; Megan Meyer; Casie A Genetti; Giovanni Meola; Rosanna Cardani; Emma Mathews; Heinz Jungbluth; Francesco Muntoni; Francesco Zorzato; Susan Treves
Journal:  Hum Mutat       Date:  2019-04-01       Impact factor: 4.878

4.  Dstac is required for normal circadian activity rhythms in Drosophila.

Authors:  I-Uen Hsu; Jeremy W Linsley; Jade E Varineau; Orie T Shafer; John Y Kuwada
Journal:  Chronobiol Int       Date:  2018-04-05       Impact factor: 2.877

5.  Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variants.

Authors:  Senthilkumar Sadhasivam; Barbara W Brandom; Richard A Henker; John J McAuliffe
Journal:  Pharmacogenomics       Date:  2019-09       Impact factor: 2.533

Review 6.  Genetics and signaling mechanisms of orofacial clefts.

Authors:  Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-07-15       Impact factor: 2.344

Review 7.  Ca2+ Release Channels Join the 'Resolution Revolution'.

Authors:  Ran Zalk; Andrew R Marks
Journal:  Trends Biochem Sci       Date:  2017-05-09       Impact factor: 13.807

8.  Recessive MYF5 Mutations Cause External Ophthalmoplegia, Rib, and Vertebral Anomalies.

Authors:  Silvio Alessandro Di Gioia; Sherin Shaaban; Beyhan Tüysüz; Nursel H Elcioglu; Wai-Man Chan; Caroline D Robson; Kirsten Ecklund; Nicole M Gilette; Azmi Hamzaoglu; Gulsen Akay Tayfun; Elias I Traboulsi; Elizabeth C Engle
Journal:  Am J Hum Genet       Date:  2018-06-07       Impact factor: 11.025

9.  RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.

Authors:  Paul J Isackson; Jianxin Wang; Mohammad Zia; Paul Spurgeon; Adrian Levesque; Jonathan Bard; Smitha James; Norma Nowak; Tae Keun Lee; Georgirene D Vladutiu
Journal:  Pharmacogenomics       Date:  2018-10-16       Impact factor: 2.533

Review 10.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.